This is why we need the OTC to come back into play. The reason we're in stocks is to make $$$$$$. No other reason and we need excitement even if its pure BS.
Recent AGLE News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2024 04:15:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/25/2024 08:55:38 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/25/2024 08:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2024 08:21:55 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/01/2024 08:06:29 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/20/2024 11:14:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/18/2024 08:06:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 12:31:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/14/2024 08:12:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:33:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:36:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:33:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:32:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:27:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:25:02 PM
- Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD • PR Newswire (US) • 11/27/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/23/2023 01:45:06 AM
- Aeglea BioTherapeutics Announces Grants of Inducement Awards • PR Newswire (US) • 11/22/2023 10:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/15/2023 10:18:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 10:14:01 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM